aloe emodin and Glial Cell Tumors
aloe emodin has been researched along with Glial Cell Tumors in 4 studies
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Abdul Ghani, AR; Abdullah, JM; Haris, K; Ismail, S; Johan, MF; Mohamed Yusoff, AA | 1 |
Acevedo-Duncan, M; Patel, R; Patel, S; Russell, C | 1 |
Harhaji, Lj; Maksimovic-Ivanic, D; Mijatovic, S; Miljkovic, Dj; Mostarica Stojkovic, M; Radovic, J; Stosic-Grujicic, S; Trajkovic, V; Vuckovic, O | 1 |
Kaludjerovic, GN; Maksimovic-Ivanic, D; Mijatovic, S; Miljkovic, D; Radovic, J; Sabo, TJ; Trajkovic, V | 1 |
Other Studies
4 other study(ies) available for aloe emodin and Glial Cell Tumors
Article | Year |
---|---|
Enhanced induction of cell cycle arrest and apoptosis via the mitochondrial membrane potential disruption in human U87 malignant glioma cells by aloe emodin.
Topics: Aloe; Anthraquinones; Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Proliferation; Glioma; Humans; Membrane Potential, Mitochondrial; Mitochondria; Molecular Structure; Plant Leaves | 2013 |
Aloe-emodin modulates PKC isozymes, inhibits proliferation, and induces apoptosis in U-373MG glioma cells.
Topics: Anthraquinones; Apoptosis; Blotting, Western; Brain Neoplasms; Cell Cycle; Cell Fractionation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; DNA; Emodin; Glioma; Humans; Isoenzymes; Neuroglia; Protein Kinase C; S Phase | 2004 |
Anti-glioma action of aloe emodin: the role of ERK inhibition.
Topics: Animals; Anthraquinones; Antineoplastic Agents, Phytogenic; Apoptosis; Autolysis; Cell Differentiation; Cell Line, Tumor; Emodin; Extracellular Signal-Regulated MAP Kinases; Glioma; Rats | 2005 |
Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Antagonism; Emodin; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibrosarcoma; Flavonoids; Glioma; Mice; Platinum; Rats; Structure-Activity Relationship | 2005 |